|
|
Participating
Faculty:
Anthony Campagnari, Ph.D., Terry D. Connell, Ph.D., Steven Gill, Ph.D., Anders Hakansson, Ph.D., Mark R. O'Brian, Ph.D., Thomas A. Russo, M.D., Mark D. Sutton, Ph.D.
Research in bacteriology is
focused in a number of areas. Vaccine development against
M. catarrhalis and H. influenzae is the
primary goal of the Murphy laboratory. The Campagnari
laboratory is currently studying Haemophilus ducreyi
and Moraxella catarrhalis. H. ducreyi causes the
sexually transmitted disease chancroid, which has been implicated
as a cofactor in HIV transmission. M. catarrhalis
is a human respiratory pathogen that is a major cause of otitis
media in young children. In collaboration with the Russo
laboratory, a combination of monoclonal antibody technology
and molecular biology has identified an outer membrane protein
with attractive vaccine characteristics. The primary focus
of the Russo laboratory is
the identification and characterization of novel genes expressed
by extra intestinal isolates of Escherichia coli,
in vivo. Using transposon mutagenesis in an ex vivo
environment new genes have been identified which appear to
be important in pathogenesis. A primary focus of the Connell
lab is to investigate the molecular mechanisms of iron acquisition
by the upper respiratory pathogens of the genus Bordetella
that influence virulence. Regulation of heme biosynthesis during symbiosis
of soybean by Bradyrhizobium japonicum is the main
focus of the O'Brian
lab. Anders Hakansson has recently joined the Center. Work in the Hakansson laboratory is focused on examination of the interaction of streptococcus pneumoniae with host cells in the respiratory tract.
|
|